Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
Open accessThe DOI matches its Crossref record.
Abstract
The native capsular polysaccharide of type III group B Streptococcus elicits a specific antibody response in only 60% of nonimmune human subjects. To enhance the immunogenicity of this polysaccharide, we coupled the type III polysaccharide to tetanus toxoid. Prior to coupling, aldehyde groups were introduced on the polysaccharide by controlled periodate oxidation, resulting in the conversion of 25% of the sialic acid residues of the polysaccharide to residues of the 8-carbon analogue of sialic acid, 5-acetamido-3,5-dideoxy-D-galactosyloctulosonic acid. Tetanus toxoid was conjugated to the polysaccharide by reductive amination, via the free aldehyde groups present on the partially oxidized sialic acid residues. Rabbits vaccinated with the conjugate vaccine produced IgG antibodies that reacted with the native type III group B streptococcal polysaccharide (3/3 rabbits), while rabbits immunized with the unconjugated type III polysaccharide failed to respond (0/3 rabbits). Sera from animals receiving conjugate vaccine opsonized type III group B streptococci for phagocytic killing by human peripheral blood leukocytes, and protected mice against lethal challenge with live type III group B streptococci. The results suggest that this method of conjugation to a carrier protein may be a useful strategy to improve the immunogenicity of the type III group B Streptococcus polysaccharide in human subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Boes, M., Prodeus, A. P., Schmidt, T., Carroll, M. C., & Chen, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2381 · Cited by 554
Wessels, M. R., Butko, P., Ma, M., Warren, H. B., Lage, A. L., & Carroll, M. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11490 · Cited by 503
Self-citationA Population-Based Assessment of Invasive Disease Due to Group B Streptococcus in Nonpregnant Adults
Farley, M. M., Harvey, C., Stull, T., Smith, J. D., Schuchat, A., Wenger, J. D., & Stephens, D. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282503 · Cited by 496
Carlin, A. F., Uchiyama, S., Chang, Y.-C., Lewis, A. L., Nizet, V., & Varki, A. (2009) · Blood · doi:10.1182/blood-2008-11-187302 · Cited by 401
Avci, F. Y., Li, X., Tsuji, M., & Kasper, D. L. (2011) · Nature Medicine · doi:10.1038/nm.2535 · Cited by 366
Self-citationGroup B Streptococcus: global incidence and vaccine development
Johri, A. K., Paoletti, L. C., Glaser, P., Dua, M., Sharma, P. K., Grandi, G., & Rappuoli, R. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1552 · Cited by 333
Self-citationMannose-targeted systems for the delivery of therapeutics
Irache, J. M., Salman, H. H., Gamazo, C., & Espuelas, S. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.703 · Cited by 293
Marques, M. B., Kasper, D. L., Pangburn, M. K., & Wessels, M. R. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.3986-3993.1992 · Cited by 270
Self-citationImmune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Kasper, D. L., Paoletti, L. C., Wessels, M. R., Guttormsen, H. K., Carey, V. J., Jennings, H. J., & Baker, C. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119042 · Cited by 264
Self-citationMaternal vaccination: moving the science forward
Faucette, A. N., Unger, B. L., Gonik, B., & Chen, K. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu041 · Cited by 81
Metadata
- Authors
- Wessels, M. R., Paoletti, L. C., Kasper, D. L., DiFabio, J. L., Michon, F., Holme, K., & Jennings, H. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1990-11-01
- Volume
- 86
- Issue
- 5
- Pages
- 1428-1433
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1978287409
- Cited by
- 191
- References
- 0
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.